ChartMill assigns a Buy % Consensus number of 80% to BNTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-22 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-05 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-16 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-06-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-03 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-05-29 | Goldman Sachs | Initiate | Neutral |
| 2025-05-22 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-06 | Citigroup | Maintains | Buy -> Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-13 | Citigroup | Initiate | Buy |
| 2025-03-11 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-01-10 | Truist Securities | Initiate | Buy |
| 2024-12-11 | Wells Fargo | Initiate | Overweight |
| 2024-11-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-26 | JP Morgan | Maintains | Neutral -> Neutral |
29 analysts have analysed BNTX and the average price target is 138.91 USD. This implies a price increase of 42.63% is expected in the next year compared to the current price of 97.39.
The consensus rating for BIONTECH SE-ADR (BNTX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.